Fresh Tracks Therapeutics Inc (FRTX)

  • Get an in-depth profile of Fresh Tracks Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

Select Exchange

Symbol Exchange Currency
FRTX NASDAQ USD Real-time VCCG Frankfurt EUR Delayed
0.8101 +0.0215 (+2.73%)
Closed USD Disclaimer
0.8498 +0.0397 (+4.9006%)

Fresh Tracks Therapeutics Inc Company Profile

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
13
Equity Type
ORD
Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops FRTX-02 (BBI-02), an oral DYRK1A inhibitor that is completed Phase 1 clinical trials for the treatment of autoimmune and inflammatory diseases; FRTX-10 (BBI-10), a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases; and FRTX-03, a topical DYRK1A inhibitor for the treatment of mild-to-moderate skin conditions, as well as next-generation kinase inhibitors. Fresh Tracks Therapeutics, Inc. has license and collaboration agreements with Carna Biosciences, Inc., and Voronoi Inc. The company was formerly known as Brickell Biotech, Inc. and changed its name to Fresh Tracks Therapeutics, Inc. in September 2022. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.
Contact Information
Address
Boulder,80301 United States
Phone
720 505 4755
Fax
-
Web
https://www.frtx.com
Top Executives
Name
Age
Since
Title
Albert Nicholas Marchio 71 2022 CEO, CFO, Secretary & Chairman
Bridget Wagner 0 2022 Member of Scientific Advisory Board
Bernard Khor 0 2022 Member of Scientific Advisory Board
Pui Lee 0 2022 Member of Scientific Advisory Board
Peter A. Nigrovic 0 2022 Member of Scientific Advisory Board
Katherine Fitzgerald 0 2022 Member of Scientific Advisory Board

Customize

Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.